EHRA Premium Access

Is thyroid function testing necessary in all cases of new onset atrial fibrillation diagnosed in the emergency department? - a real-life study

Congress Presentation

About the speaker

Doctor Jakob Hytting

Vrinnevi Hospital, Norrkoping (Sweden)
2 followers

7 more presentations in this session

Effects of sodium glucose co-transporter-2 inhibitor on atrial tachyarrhythmia burden in patients with cardiovascular implantable electronic device

Speaker: Assistant Professor T. Nantsupawat (Chiang Mai, TH)

Thumbnail

Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke

Speaker: Professor A. Jadidi (Luzern, CH)

Thumbnail

Incidence and outcome of periinterventional atrial fibrillation in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Speaker: Mr J. Jost (Vienna, AT)

Thumbnail

Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

Speaker: Doctor B. Corica (Modena, IT)

Thumbnail

Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial

Speaker: Doctor L. Xing (Copenhagen, DK)

Thumbnail

Access the full session

Atrial fibrillation: clinical

Speakers: Doctor J. Hytting, Assistant Professor T. Nantsupawat, Professor A. Jadidi, Mr J. Jost, Doctor B. Corica...
Thumbnail

About the event

Image

EHRA 2024

7 April - 9 April 2024

Sessions Presentations